Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Myat Min Han"'
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 43-47 (2022)
Acalabrutinib, a second-generation and more selective Bruton's tyrosine kinase inhibitor, was developed to potentiate efficacy while minimizing ibrutinib-associated side effects. We undertook a systematic review and meta-analysis of randomized clinic
Externí odkaz:
https://doaj.org/article/c0220c93af63480281ddf320b0d8004f
Publikováno v:
Journal of Immunotherapy and Precision Oncology. 5:43-47
Acalabrutinib, a second-generation and more selective Bruton's tyrosine kinase inhibitor, was developed to potentiate efficacy while minimizing ibrutinib-associated side effects. We undertook a systematic review and meta-analysis of randomized clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d0e2c99232c74e0c67079c060e14a8c
https://doi.org/10.36401/jipo-21-12
https://doi.org/10.36401/jipo-21-12
Autor:
Kyaw Zin Thein, Thura Win Htut, Myat Min Han, Yin Mon Myat, Myint Aung Win, Ei Moe Phyu, Thein H. Oo
Publikováno v:
Blood. 140:10887-10888
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::668c27cc4a39f07f25e3d504fc277f16
https://doi.org/10.1182/blood-2022-165629
https://doi.org/10.1182/blood-2022-165629
Autor:
Kyaw Zin Thein, Thura Win Htut, Myat Min Han, Yin Mon Myat, Myint Aung Win, Ei Moe Phyu, Thein H. Oo
Publikováno v:
Blood. 140:7997-7998
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40015189eb10cc2c6cc9ebb6d1906c64
https://doi.org/10.1182/blood-2022-165666
https://doi.org/10.1182/blood-2022-165666
Autor:
Myat Min Han, Patrick Chaftari, K. Jacobson, Imad El Majzoub, Aiham Qdaisat, Myint Aung Win, Sai Ching J. Yeung, Cielito C. Reyes-Gibby, Michael Prejean, Kyaw Zin Thein
Publikováno v:
Annals of emergency medicine. 73(1)
Study objective Cancer immunotherapy is evolving rapidly and is transforming cancer care. During the last decade, immune checkpoint therapies have been developed to enhance the immune response; however, specific adverse effects related to autoimmunit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68fb9ba5b428dc74b53735548350c30a
https://pubmed.ncbi.nlm.nih.gov/30243546
https://pubmed.ncbi.nlm.nih.gov/30243546
Autor:
Myat Min Han, Mark Currie, Lukman Tijani, Kenneth Pendergrast, Kyaw Zin Thein, Donald P. Quick, Myint Aung Win, Nicholas D'Cunha, Ei Moe Phyu
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S242-S243
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ee3423d2a64f30268c6a3590dfd64c4
https://doi.org/10.1016/j.clml.2018.07.135
https://doi.org/10.1016/j.clml.2018.07.135
Autor:
Ei Moe Phyu, Prospero Cortorreal, Myint Aung Win, Lukman Tijani, Myat Min Han, Edward Griffin, Kyaw Zin Thein, Donald P. Quick
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S241-S242
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7780b840ccff057f05e7cffd41f89ccb
https://doi.org/10.1016/j.clml.2018.07.133
https://doi.org/10.1016/j.clml.2018.07.133
Autor:
Ei Moe Phyu, Anita Sultan, Thura Win Htut, Sriman Swarup, Nyein Htway Yu, Myat Min Han, Bradley J. Grant, Kyaw Zin Thein, Nimesh Adhikari, Myint Aung Win, Nicholas D'Cunha, Yin Mon Myat, Chandler Graf, Donald P. Quick
Publikováno v:
Blood. 134:5877-5877
Introduction: Chronic lymphocytic leukemia is the most prevalent adult leukemia in western countries. Phosphatidylinositol 3-kinase (PI3K) is a kinase protein involved in downstream signaling for the B-cell receptor signaling pathway and has been sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::893f4829b7ba7de6d6f0bcfd50f73642
https://doi.org/10.1182/blood-2019-123531
https://doi.org/10.1182/blood-2019-123531
Autor:
Thura Win Htut, Somedeb Ball, Myat Min Han, Ei Moe Phyu, Myint Aung Win, Anita Sultan, Donald P. Quick, Nicholas D'Cunha, Lukman Tijani, Kyaw Zin Thein, Ramesh Kumar Pandey, Aung M. Tun, Sriman Swarup, Fred Hardwicke
Publikováno v:
Blood. 134:3158-3158
Introduction: Management of newly diagnosed multiple myeloma (NDMM), which accounts for 1% of all cancers, is an area in dire need of therapeutic innovation. In recent years, the introduction of novel agents is one of the major advances in the manage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abdcb3d3be88c75599a3b345dc164415
https://doi.org/10.1182/blood-2019-123131
https://doi.org/10.1182/blood-2019-123131
Autor:
Fred Hardwicke, Lukman Tijani, Sriman Swarup, Thura Win Htut, Nicholas D'Cunha, Pwint Phyu Hlaing, Kyaw Zin Thein, Myat Min Han, Yin Mon Myat, Khaing Khaing Htwe, Anita Sultan, Akshar Dash, Sariya Wongsaengsak, Donald P. Quick
Publikováno v:
Blood. 134:2200-2200
Introduction: Bruton's tyrosine kinase (BTK) is a kinase involved in cellular signaling downstream of the B cell receptor and is involved in B-cell survival and proliferation. Hence, BTK inhibitors have become an attractive therapeutic target for a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79d94228bec1ea052dc526f096fce2e0
https://doi.org/10.1182/blood-2019-123261
https://doi.org/10.1182/blood-2019-123261